Transferrin receptor (TfR, CD71) is an integral membrane glycoprotein that
mediates cellular uptake of iron. In most tissues, TfR expression is correl
ated positively with proliferation and regulated at the post-transcriptiona
l level. The available data regarding the pattern of TfR gene expression in
haematological malignancies are very Limited. In the present study, we eva
luated TfR gene expression at the molecular level in bone marrow (BM) sampl
es of 44 patients with de novo acute myeloid leukaemia (AXIL) at diagnosis
with BM blasts > 85%. TfR mRNA levels were determined by densitometric anal
ysis of quantitative reverse transcription polymerase chain reaction produc
ts corresponding to TfR exons 15-17. Each sample was tested in at least two
independent experiments. In 13/44 patients, TfR messages were not detected
(this is probably an underestimate as some positive results may be attribu
ted to residual normal erythroid cells present in the samples). In 17/44, T
fR mRNA levels were low-intermediate, and were high in the remaining patien
ts (14/44). TfR mRNA positivity was significantly associated with older age
. No statistically significant correlations were found either with specific
French-American-British (FAB) subtypes or attainment of complete remission
, incidence of relapse and survival (after adjusting accordingly for age an
d FAB subtype). The absence of TfR mRNA transcripts in a significant minori
ty of cases suggests that alternative mechanisms of iron uptake may functio
n in AML blast cells.